2017
DOI: 10.1007/s10067-017-3761-z
|View full text |Cite
|
Sign up to set email alerts
|

Africa Journal of Rheumatology: enhancing the visibility of rheumatology in Africa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 3 publications
(4 reference statements)
0
2
0
Order By: Relevance
“…There are 6–7 million children globally living with rheumatic diseases, with a large majority of these children residing in low resource income countries [ 1 4 ]. The true prevalence of disease is likely underestimated given the lack of epidemiological data and the burden of other conditions including malnutrition and infectious communicable diseases often take precedence in health care resource priority over chronic musculoskeletal (MSK) conditions [ 5 ]. Children with rheumatic conditions go unrecognized for many reasons including greater focus on other health care burdens in low-income countries and being lost in the ‘abyss of the unmet global MSK health care need.’ Despite there being effective treatments available, there is often marked delay to appropriate care resulting in worse clinical and socioeconomic outcomes, irreversible joint damage, lifelong disability, lower quality of life, and increased mortality [ 2 , 6 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…There are 6–7 million children globally living with rheumatic diseases, with a large majority of these children residing in low resource income countries [ 1 4 ]. The true prevalence of disease is likely underestimated given the lack of epidemiological data and the burden of other conditions including malnutrition and infectious communicable diseases often take precedence in health care resource priority over chronic musculoskeletal (MSK) conditions [ 5 ]. Children with rheumatic conditions go unrecognized for many reasons including greater focus on other health care burdens in low-income countries and being lost in the ‘abyss of the unmet global MSK health care need.’ Despite there being effective treatments available, there is often marked delay to appropriate care resulting in worse clinical and socioeconomic outcomes, irreversible joint damage, lifelong disability, lower quality of life, and increased mortality [ 2 , 6 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…This special collection on rheumatology in Africa reflects a new dawn for rheumatology on the continent as well as the continuing strong support of Clinical Rheumatology for the development of African rheumatology [ 1 ]. In contrast to earlier reports, rheumatological conditions are now not considered to be rare in Africa and the articles within this collection reflect this.…”
mentioning
confidence: 99%